1. L2 In vivo live imaging of human T/B cell lymphoma cross-linking mediated by bispecific CD20-TCB antibody. (1st October 2020) Authors: Cremasco, F; Menietti, E; Speziale, D; Sam, J; Sammicheli, S; Chen, S; Richard, M; Klein, C; Umana, P; Bacac, M; Colombetti, S; Perro, M Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 2 Page Start: A1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. P01.01 PLAP as target for cancer immunotherapy – development and preclinical characterization of bispecific monoclonal antibody in colorectal cancer immunotherapy. (21st September 2022) Authors: Alrishedan, NS; Bodmer, W; Liebe lastun, V; Golubovskaya, V; Wu, J; Bransi, A; Umana, P; Klein, C; Mateus Seidl, R Journal: Journal for immunotherapy of cancer Issue: Volume 10(2022)Supplement 1 Page Start: A8 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. P09.02 Modular P329G-binding CAR T cells engineered to recognize human effector-silenced antibodies carrying a P329G Fc-mutation for targeting of solid tumor antigens. (21st September 2022) Authors: Stock, S; Benmebarek, M; Kluever, A; Darowski, D; Jost, C; Stubenrauch, K; Benz, J; Freimoser-Grundschober, A; Moessner, E; Umana, P; Subklewe, M; Endres, S; Klein, C; Kobold, S Journal: Journal for immunotherapy of cancer Issue: Volume 10(2022)Supplement 1 Page Start: A32 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗